Contributed by Hal S. Stern, PhD and Frank M. LaFerla, PhD It is our pleasure to congratulate Charles Glabe, Distinguished Professor of Molecular Biology and Biochemistry, on being named a 2020 fellow of the National Academy of Inventors. Among his achievements, Professor Glabe is being recognized for the creation of antibodies that bind to the four kinds of proteins forming the amyloid associated with Alzheimer's disease. The process enables scientists to detect individual forms of the disease more precisely. The antibodies can be used as a screening tool and could help develop immunotherapies that slow or even prevent Alzheimer's. Professor…
Read More
Contributed by Michelle McDonnell, PhD A common recommendation to participants at UCI MIND is to remain “physically, socially, and cognitively active.” While one can easily understand how to implement the recommendations for increased social and physical activity, it is more challenging to understand what types of cognitive activities there are and how to increase them in a meaningful way. This blog defines what we mean when we recommend increasing cognitive activity and provides some examples you can easily implement in your day-to-day life. Cognitive activity (sometimes referred to as cognitive stimulation) is defined as complex mental activity that can potentially promote…
Read More
Did you know that Asians, including Korean Americans are among the least represented groups in health research? CARE stands for "Collaborative Approach for Asian Americans & Pacific Islanders Research & Education". The goal of the CARE Registry is to connect Asian Americans and Pacific Islanders to various types of research that may make a difference in improving the health of you, your family and future generations. Please join Dr. Hye-Won Shin, Director of Asian American Outreach of UCI Institute for Memory Impairments and Neurological Disorders (UCI MIND), and CARE Community Advisory Board member for the 1st CARE Registry Korean Virtual Information Session! This session will be offered…
Read More
ASK THE DOC! UCI MIND Facebook LIVE Video Series This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Can stem cells treat Alzheimer's disease and related disorders? About the Speaker: Dr. Blurton-Jones is an Associate Professor of Neurobiology & Behavior in the UCI School of Biological Sciences, and he leads the induced...
Tomorrow A December to Remember Gala, presented by UCI MIND and the Harris Taylor Family, is tomorrow! We look forward to an evening of music, magic, and memories for Alzheimer's research. Pre-Show at 5:30 PM PST Live Program at 6:00 - 7:00 PM PST Three Viewing Options: YouTube Live (watch on your Smart TV) Facebook Live (interact with other viewers) Gala Website (quick access to auction items) Live Stream Link Silent Auction The gala auction is now live and closes Monday, December 7 at 12:00 PM PST. Two Ways to Bid: Visit mind.uci.edu/bid Text MIND to 61094 View Auction Presenting Sponsor Harris…
Read More
Getty Images MarketWatch - Nov. 30, 2020 The University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) has studied elderly individuals as part of its “90+ Study” since 2003, analyzing the ways in which nearly 2,000 participants go about their lives in their 90s and 100s, as well as what may have contributed to that longevity and underlying cognitive disabilities they may or may not know they have. … Half of children born this decade can expect to see their 103rd or 104th birthday, Claudia Kawas, co-principal investigator of The 90+ Study, told CBS. Read more >
Read More
Today is Giving Tuesday, a celebration of generosity and philanthropy, and a global movement to harness the power of community for the greater good. At UCI MIND, we rely on the support of our community to advance life-changing research and continue the fight against Alzheimer’s disease, a debilitating illness that impacts more than 5.8 million Americans and their families. This Giving Tuesday, we hope you will expand our capacity to conduct promising research and accelerate progress toward a world without Alzheimer’s disease by supporting the Alzheimer’s Disease Excellence Fund. Our goal is to rid the world of Alzheimer’s disease. We…
Read More
Today is Giving Tuesday, and UCI MIND could use your help during this year’s international day of philanthropy. We hope you will support us by: Staying connected! Visit this link for ways to follow UCI MIND and keep informed of brain health, Alzheimer’s disease and related dementia research. Making a gift! Click here to donate to the Alzheimer’s Disease Excellence Fund. Your donation of any amount will help advance research into the treatment, prevention, diagnosis and care for Alzheimer’s disease and related dementias. At UCI MIND, our goal is to rid the world of Alzheimer’s disease. We need the power…
Read More
Alzheimer’s Biomarker Consortium – Down Syndrome (ABC-DS) Award The University of California, Irvine is undertaking a five-year, multi-million dollar project to expand research on Alzheimer’s disease in people with Down syndrome. The National Institute of Health awarded a $109 million grant to the Alzheimer’s Biomarkers Consortium-Down Syndrome in late October. The international team, led by UCI principal investigators Elizabeth Head and Mark Mapstone, aims to identify biomarkers that indicate the progression of Alzheimer’s disease in adults with Down syndrome. Subscribers to the Orange County Business Journal can read more here >
Read More
Dear friends of UCI MIND, Last week, Maria Shriver and the Governor's Task Force on Alzheimer's Prevention and Preparedness presented a report describing their 10 recommendations to Governor Gavin Newsom. Click here to view the report. The Governor was extremely receptive to the recommendations. We anticipate movement in the coming months to years on these important initiatives to improve the lives of Californians living with dementia and their families and to increase Alzheimer’s awareness, risk reduction education, and research. We would like to thank the many UCI MIND stakeholders who participated in the Task Force listening session as part of…
Read More
Will Biogen’s aducanumab become the first drug approved to slow progression of Alzheimer’s disease? UCI MIND faculty member and chair of UCI Statistics, Dr. Daniel Gillen, and other experts comment on ALZFORUM.
Read More
Contributed by UCI MIND Nurse Practitioner, Catherine McAdams-Ortiz, MSN, RN, A/GNP Have you noticed the Holiday decorations popping up at shopping malls already? Yes, the Holiday Season is upon us. This year, due to the COVID-19 pandemic, we all need to carefully plan our social gatherings, meals, and guests in our homes. Hopefully, you will find some helpful hints here so you can safely navigate all the Holidays you will celebrate this year. The very best gift you can give yourself, your loved ones and your friends is to make sure you get your flu vaccine as soon as possible.…
Read More
CBS: Six years after our initial report, Lesley Stahl visits surviving members of the 90+ Study and finds out what scientists have learned from following the study's participants. We're a nation living longer and longer. Over the next 30 years, the number of Americans age 90 and above is expected to triple, and an NIH-funded research study called 90+ at the University of California Irvine is trying to learn all it can right now from a group of men and women who've already managed to get there. Six years ago, we first reported on their first set of findings. Factors…
Read More
The 90+ Study, co-led by UCI MIND faculty members Drs. Claudia Kawas and Maria Corrada, will be featured in the show “60 Minutes” this Sunday, November 22 on CBS. The episode will be a follow-up of the study participants who were featured on the show six years ago and an update on research findings since then. Learn more about the feature in the articles below: Lesley Stahl follows up with nonagenarians from landmark study on aging Is there a secret to living well into your 90s?
Read More
Contributed by UCI News: UCI’s Center for Neural Circuit Mapping is redrawing our understanding of mechanisms underlying several common disorders by Ian Anzlowar, UCI | November 18, 2020 “Our goal is to reveal the molecular changes that occur during the course of Alzheimer’s, impacting learning and memory, and identify a route toward early detection and new drug therapies for the disease,” says Xiangmin Xu, director of UCI’s Center for Neural Circuit Mapping. Steve Zylius / UCI Thanks to Xiangmin Xu and his team at the UCI School of Medicine’s Center for Neural Circuit Mapping, lazy eye, Alzheimer’s and other neurological…
Read More
Commentary on NPR article, contributed by Bryce Mander, PhD Numerous studies now show that multiple forms of sleep disturbance increase risk for developing dementia. Emerging work continues to demonstrate that the way in which the brain expresses sleep may be tied to how much Alzheimer’s disease (AD) pathology there is in the brain even prior to AD symptom onset. Both sleep restriction and suppression of high amplitude, low frequency brain waves - called slow waves - during deep sleep increase beta amyloid and tau, the two hallmark pathologies of AD. It is unknown how this occurs, though there is evidence of two potential mechanisms: increased production of AD…
Read More
UCI Consent-to-Contact (C2C) Registry In 2016, UCI MIND launched a local recruitment registry – the UCI Consent-to-Contact (C2C) Registry – to raise awareness of research participation opportunities at UCI (c2c.uci.edu). We are excited to announce that this fall, the UCI C2C went live in Spanish, Korean, Chinese, and Vietnamese to allow more people to access this online tool. Together with our diverse community, we will improve our understanding of Alzheimer's disease and related dementias in diverse populations and find solutions for people of all backgrounds. To learn more about enrolling in C2C, visit c2c.uci.edu > To read more in our latest newsletter, click here…
Read More
Message from the Director Dear Friends of UCI MIND, As the COVID-19 pandemic continues to impact our lives this fall, the fight to solve Alzheimer’s disease and related dementias (ADRD) must charge forward. This November, the U.S. FDA will convene an advisory committee to assess potential approval of Biogen’s aducanumab, a monoclonal antibody in development for treatment of early AD. We will watch closely as aducanumab could be the first new approved drug for AD since 2005. Regardless of the outcome of the meeting and subsequent FDA decision – anticipated in March 2021 – this represents a milestone for…
Read More
With the COVID-19 pandemic and social distancing measures that have been in place since March 2020, unprecedented challenges have presented for everyone working in Alzheimer’s disease clinical research and clinical trials/drug development. As many older adults are isolating themselves at home, individuals and their families are pivoting to use technology to stay connected with loved ones and one another. With common devices like smartphones, tablets, and computers with cameras, platforms for video-conferencing (i.e., Zoom, FaceTime, Skype, Facebook) become important tools for us to stay connected. Many healthcare providers have also transitioned to remote health visits, to continue to assess…
Read More
Many of us listened intently today as the US Food and Drug Administration convened a panel of expert members of an advisory committee to review the submitted materials for potential approval of Biogen’s candidate treatment for early Alzheimer’s disease, aducanumab. The meeting was notable on many levels. Advocates made clear and compelling demonstrations of why new therapies are so desperately needed for this disease. The experts, however, were equally clear that the available data from a still limited number of studies, only one of which was actually positive, do not meet the current standards for drug approval in the United…
Read More
ASK THE DOC! UCI MIND Facebook LIVE Video Series This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. How does heart health impact the brain? About the Speaker: Daniel Nation, PhD is an Associate Professor of Psychological Science in the UCI School of Social Ecology. He earned his PhD in clinical…
Read More
The FDA will today convene an advisory committee to review and discuss the application submitted by Biogen Inc. for aducanumab for the treatment of early Alzheimer's disease. Though mixed opinions remain about whether the FDA should approve aducanumab at this time, the submission of a new treatment entity for Alzheimer’s disease is nonetheless good news and an important milestone. It has been nearly two decades since a new drug was approved for Alzheimer’s disease and no approved drug can effectively slow or stop the debilitating progression of this fatal neurodegenerative disease. Regardless of the outcome of this specific submission, we…
Read More
Harriet Harris (second row center) and her family after receiving the UCI MIND Award at the 2019 “A December To Remember” gala event For the first time in the event’s decade-long history, the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND)’s A December to Remember gala will raise awareness and funds for Alzheimer’s research in a digital setting. While many sectors remain at a standstill due to the pandemic, nonprofits like UCI MIND know that their mission must march forward. The virtual gala event will take place online on Saturday, Dec. 5 from 5:30-7 p.m.,…
Read More
Contributed by Alessandra C. Martini, PhD, Associate Project Scientist at UCI MIND Researchers have discovered that the majority of people with Down syndrome will have the pathology of Alzheimer’s disease – amyloid plaques and neurofibrillary tangles - in their brains by 40 years of age. In this new study, conducted with colleagues at the University of Kentucky, we used autopsy tissue donated by research participants to analyze the role of microglia (the brain’s immune cells) in the development of Alzheimer’s disease in people with Down syndrome across different ages and disease stages. What we found is that people with Down…
Read More
“Our findings suggest that older individuals experiencing cognitive decline have relatively stable ideological preferences, but these preferences lose their connection to political policy details. Future studies conducted during an election year may shed additional light on how this group of Americans is casting their ballot,” said UCI MIND faculty member Mark Fisher, MD. Study participants were 190 members of The 90+ Study (LINK), a UCI-led longitudinal investigation of the oldest-old, who are those aged 90 and older.
Read More
Charles Limoli FLASH radiation therapy, also called FLASH-RT, can eliminate the debilitating side effects associated with traditional radiation therapy by delivering the same dose in tenths of seconds, and can remove tumors, according to a study published in Clinical Cancer Research. … Charles Limoli, PhD, a researcher and professor of radiation oncology at University of California Irvine It's not unreasonable to expect that in 10 years, this may become a widespread option for radiotherapy patients worldwide."
Read More
Amanda McQuade, graduate student in Mathew Blurton-Jones’ lab at UCI MIND, discusses findings from their new study using induced pluripotent stem cells (iPSC), donated from participants at the UCI Alzheimer’s Disease Research Center, and CRISPR gene editing to improve understanding of the role of immunity in Alzheimer’s disease. Click below to view the video, and access the publication at this link: https://www.nature.com/articles/s41467-020-19227-5 Amanda McQuade, MS Amanda McQuade is a graduate student in the department of Neurobiology and Behavior working with Dr. Mathew Blurton-Jones. Her graduate work focuses on using CRISPR to study risk mutations for Alzheimer’s disease in human…
Read More
UCI MIND & UCI School of Nursing present a live Q&A panel: Caring for the Caregiver Tuesday, November 10, 2020 4:00 - 5:30 pm PDT Live on Facebook & YouTube Join us for a virtual discussion and Q&A with experts on the unique challenges facing dementia caregivers during the COVID-19 pandemic. Panelists include Dr. Joshua Grill, director of UCI MIND, Drs. Alison Holman and Jung-Ah Lee, faculty in the UCI School of Nursing, and Dr. Lisa Gibbs, medical director of UCI Senior Health Center. Register online to receive live viewing instructions.
Read More
The actual number of deaths linked to dementia may be about three times greater than what is reported on U.S. death certificates, according to a recent NIA-supported study. The findings were published online August 24, 2020, in JAMA Neurology. Previous studies have established that doctors and medical examiners may be underreporting Alzheimer’s disease and related dementias as an underlying cause of death on death certificates. To investigate whether the impact from the underreporting was substantial, a research team led by investigators at Boston University compared dementia-related deaths determined by a nationally representative study to what is reported on death certificates.…
Read More
UC San Francisco, UC Davis, UC Irvine, National Asian Pacific Center on Aging (NAPCA), International Children Assistance Network (ICAN) in partnership with over twenty community partners serving diverse Asian Americans and Pacific Islanders (AAPI) communities in California and nationwide, is pleased to announce the launch of the Collaborative Approach for AAPI Research and Education (CARE) research registry. The CARE registry team reflect multiple diverse AAPI cultures and languages. CARE is an opportunity for AAPI to participate in important research that may affect ourselves, our parents, children and grandchildren. Some of the important research may contribute to finding cures for and/or ways to…
Read More
Congratulations to UCI MIND investigators, Drs. Elizabeth Head and Mark Mapstone, on earning a 5-year $100 million grant to study biomarkers for Alzheimer’s disease in people with Down syndrome. The Alzheimer’s Biomarker Consortium – Down Syndrome (ABC-DS) evolved from the longstanding contributions of Dr. Ira Lott and Eric Doran who had the insight to include older people with Down syndrome in Alzheimer’s disease research. People with Down syndrome are at very high risk for Alzheimer disease as their extra copy of chromosome 21 leads to accelerated amyloid buildup with aging. The new grant will help researchers improve understanding of the unique disease progression…
Read More
Contributed by Franklin Garcia, PhD, UCI MIND Postdoctoral Fellow “On this Research Diversity Day, I would like to share my early undergraduate experience that paved the way for my interest in aging research. Franklin Garcia, PhD, UCI MIND Postdoctoral Fellow The concept of pursuing a career in scientific research was new to me since, as a first-generation university student, I didn’t have mentors or older peers that could shed some insight or guidance. Fortunately, during my last two years as an undergraduate student at UC Irvine, I received mentorship from my research advisor, Prof. Frank LaFerla and the faculty…
Read More
Alzheimer syndrom screening.The presentation is made by me based on real scientific knowledge in the public domain. (3-minute listen) After cases began emerging worldwide, thousands of clinical trials unrelated to COVID-19 were paused or canceled amid fears that participants would be infected. But now, some researchers are finding ways to carry on in spite of the coronavirus. "It's been a struggle of course," says Joshua Grill, who directs the Institute for Memory Impairments and Neurological Disorders at the University of California, Irvine. "But I think there's an imperative for us to find ways to move forward."
Read More
Congratulations to Maria Shriver for being selected as Variety's Entertainment Philanthropist of the Year for her trailblazing Alzheimer’s advocacy! Maria Shriver UCI MIND is honored to partner with Shriver and her organization, the Women's Alzheimer's Movement (WAM), to unravel why 2 out of every 3 people with Alzheimer’s are women. Thanks to Shriver and other local philanthropists, the UCI MIND-WAM Women’s Initiative has now awarded $400,000 to UCI scientists for sex and gender disparities research. Variety: “So much of my work is about awareness, prevention, funding of research and trying to educate people about something they think they don’t have…
Read More
"We'll likely continue to see a surge of cases in the fall and over the holidays," says Karen Edwards, a professor and epidemiologist at the University of California, Irvine. "If you must travel, be sure to follow all recommendations, including checking with destinations and events you plan to attend to be sure that travel to that destination or event is still possible. Cancel your trip if you have any symptoms of COVID-19 or concerns about risk of infection."
Read More
Thank you to our community for helping us exceed 500 subscribers on YouTube! If you're not yet up to date on our dementia education, visit our page, click the subscribe button and the bell icon to receive notifications, and explore our library of content. https://www.youtube.com/ucimind
Read More
Irvine, Calif. – October 15, 2020 – The National Institutes of Health has awarded a team of researchers, led by the University of California, Irvine’s Xiangmin Xu, PhD, a five-year, $3 million grant for a project titled, “Single-Cell Analysis of Aging-Associated 4D Nucleome in the Human Hippocampus.” Now, as part of the 4D Nucleome consortium, Xu, a professor of anatomy and neurobiology and director of the Center for Neural Circuit Mapping at the UCI School of Medicine, together with MPIs, Carl Wayne Cotman, PhD, a professor of neurology and founding director of the UCI Institute for Brain Aging and Dementia,…
Read More
“There are many misperceptions of what ‘capacity to vote’ is,” said Charles Sabatino, director of the American Bar Association Commission on Law and Aging. “Incapacity to follow a recipe and cook dinner doesn’t mean incapacity to vote. The inability to remember your grandchildren’s names doesn’t mean you can’t vote.” What is required — as the commission and the Penn Memory Center point out in a new guide — is the ability to express a preference. “Can you pick among the choices?” said Dr. Jason Karlawish, a geriatrician and co-director of the Penn Memory Center. “That’s it.”
Read More
You’re invited to the 11th Annual A December to Remember Gala benefiting Alzheimer's research at UCI MIND! This year’s virtual event will feature inspiring testimonials, an online auction, and engaging performances. Registration is complimentary. Meal delivery options are available for purchase for Orange County residents. For more information and sponsorship opportunities, please contact Linda Scheck at 949.824.3251 or LScheck@uci.edu. Learn More & Register: https://gala.mind.uci.edu Add to Calendar: Apple Outlook Google
Read More
Mark your calendar for upcoming virtual events! Wellness Wednesday: Healthy Brain Aging Live Q&A with Joshua Grill, PhD and Ruth Benca, MD, PhD moderated by Debra Hill, MD, UCI School of Medicine Alumni Board Wednesday, October 28, 2020 | 7:00 - 8:00 pm PDT Register online: Click here How does heart health impact the brain? Live Q&A with Daniel Nation, PhD Friday, November 6, 2020 | *1:00 - 1:30 pm PST* Tune in on Facebook: facebook.com/ucirvinemind Caring for the Caregiver Live Q&A panel on the unique challenges facing dementia caregivers during the COVID-19 pandemic, moderated by Joshua Grill, PhD Tuesday, November 10, 2020 | 4:00 -…
Read More
Contributed by Jean Paul Chadarevian & Amanda McQuade Dr. Emmanuelle Charpentier and Dr. Jennifer A. Doudna make history as the first all-female team to be awarded the Nobel Prize in Chemistry for their pioneering discovery of CRISPR-Cas9, a highly specific and efficient genome editing technology. Emmanuelle Charpentier and Jennifer A. Doudna (Photo by /Invision/AP) Charpentier, Director at the Max Planck Institute for Infection Biology in Berlin, and Doudna, biochemist at the UC Berkeley, first described the CRISPR-Cas9 system in their 2012 publication in Science. CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, was first observed in the bacterial immune system.…
Read More
Join UCI School of Nursing and UCI MIND for a virtual discussion and Q&A with experts on the unique challenges facing dementia caregivers during the COVID-19 pandemic. Nov. 10, 2020 | 4:00-5:30 PM PDT Register today: mind.uci.edu/register
Read More
Wellness Wednesday: Healthy Brain Aging October 28, 2020 7 - 8 p.m. PDT Via Zoom Join us for a live presentation and Q&A with UCI School of Medicine faculty and Alzheimer’s researchers, Joshua Grill, Ph.D., Director of UCI MIND, and Ruth Benca, M.D., Ph.D., Director of UCI Sleep Center. Learn about risk factors for Alzheimer’s disease and lifestyle strategies for maintaining a healthy brain as you age. The program will be moderated by Debra A. Hill '78, M.D., Co-President of the UCI School of Medicine Alumni Chapter. Joshua Grill, Ph.D. Director of the Institute for Memory Impairments and Neurological Disorders (UCI…
Read More
The novel coronavirus pandemic and a US Postal Service slowdown may not be the only hurdles facing people with dementia who want to vote in the 2020 general election. Nearly 6 million people in the US have some form of the condition, the US Centers for Disease Control and Prevention estimates, and they represent almost 2.5% of the 253.8 million US residents who are of voting age. The oldest voters, those aged 60 years or older, are more likely to vote than younger age groups, according to the United States Elections Project; the lion’s share of people with dementia fall…
Read More
Music, Magic & Memories December 5, 2020 5:30 - 7:00 PM Join UCI MIND for the 11th Annual A December to Remember Gala, an exciting new virtual experience on Saturday, December 5. The free, virtual event will feature engaging performances, inspiring testimonials, an online auction, and delicious dining options. Mark your calendar for a memorable night at home, all in support of the quest toward a cure for Alzheimer's disease and related dementias. For more information and sponsorship opportunities, please contact Linda Scheck at 949.824.3251 or LScheck@uci.edu. Learn More & Register: https://gala.mind.uci.edu Add to Calendar: Apple Outlook Google
Read More
Epidemiology professor Karen Edwards, department of Public HealthSteve Zylius / UCI UC Irvine is providing consulting services to private businesses to develop rules and procedures to keep employees and customers safe from COVID-19 as the economy starts to open up. “As the only program in public health in Orange County, we have an obligation to assist our community,” UCI professor Karen Edwards said in a press release. “I think there’s a gap in this area for us to step up and offer these types of services. This has the potential to have a major positive impact.” Orange County was on…
Read More
Contributed by S. Ahmad Sajjadi, MD, PhD Alzheimer’s disease is and will likely remain the commonest cause of dementia. A less well-known fact, however, is that there are also other dementia causing pathologies that are commonly referred to as Alzheimer’s disease related dementia (ADRD). While the scientific community is warming up to the idea that it should consider these other causes in all dementia related research, there is a pressing need for the wider community to be informed about them. These alternative causes of dementia are often age dependent. In people who are younger than 65 years old, a…
Read More
The president is hospitalized and reporters are fighting for basic facts. What should elderly leaders — many of America’s top politicians are over 80 — reveal about their health? “It will help if reporters are medically knowledgeable, and ask the right questions, e.g. blood pressure, heart rhythm, sleep disorders,” Dr. Mark Fisher, a professor of neurology and political science at the University of California, Irvine, told me on Sunday. “The more specific and precise questions reporters ask, the better. A robust fund of knowledge by the reporter is a great advantage.”
Read More
ASK THE DOC! UCI MIND Facebook LIVE Video Series This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Can we change our genes and risk for brain diseases? About the Speaker: Marcelo Wood, PhD is a Professor and Chair of Neurobiology and Behavior in the UCI School of Biological Sciences. He…
Read More
5TH ANNUAL HUNTINGTON'S DISEASE EDUCATIONAL SYMPOSIUM SATURDAY, OCTOBER 3rd, 2020, 1:00 - 3:00 PM Join us for the 2020 Huntington's Disease Educational Symposium! Due to health concerns over the current COVID-19 pandemic, this year we will be hosting a "virtual" educational symposium. There is no cost to participate, but you must pre-register. REGISTER HERE: https://uci.zoom.us/webinar/register/WN_ekBdNftFT7OpZJmERKEBpg Once registered, you will receive an email confirmation with Zoom call-in details for the symposium. Questions? Please contact: Frances Saldana 714-393-8095 Franceshdcare@gmail.comor ucimedia@uci.edu MODERATOR: Peter Donovan, PhD, Professor, Developmental and Cell Biology, School of Biological Sciences and Biological Chemistry, School of Medicine, University of California, Irvine.…
Read More
